Skip to content
PubMed This is a summary of 65 peer-reviewed journal articles Updated
Immunology · IRF2BP2-Related Immunodeficiency

IRF2BP2-Related Immunodeficiency: A Patient Guide

At a Glance

IRF2BP2-related immunodeficiency is a rare genetic immune condition with two connected problems: too few antibodies, which can lead to repeated sinus and lung infections, and excessive inflammation that may affect the gut, skin, and joints. Care often addresses both.

What is known and what is uncertain: IRF2BP2-related disease is extremely rare, with small published cohorts. The condition varies widely from person to person, and much of its long-term management is extrapolated from broader experience with inborn errors of immunity, rather than gene-specific clinical trials.

IRF2BP2-related immunodeficiency/immune dysregulation is a rare and specific genetic condition that is an inborn error of immunity causing a Common Variable Immunodeficiency (CVID)-like antibody deficiency. Unlike standard CVID, which often has an unknown or complex cause, this condition is “monogenic,” meaning it can be traced back to a specific change in the IRF2BP2 gene. This gene normally acts as a vital “off switch” or regulator for your immune system. When it is not functioning correctly, the body struggles to maintain a healthy balance between protection and rest, leading to a unique set of challenges that involve both a weak immune defense and an overactive inflammatory response [1][2].

Living with this condition reveals what experts call a “dual nature” of the immune system. On one hand, the body cannot produce enough antibodies (immunoglobulins) to act as a shield against bacteria and viruses, making you more susceptible to recurrent infections in the sinuses and lungs. On the other hand, because the “off switch” is impaired, the immune system may stay in a constant state of alarm, attacking the body’s own healthy tissues. This often manifests as chronic gastrointestinal issues, inflammatory skin conditions like vitiligo or alopecia, and persistent joint pain [2][3].

Because the condition has these two distinct sides, management requires a “two-track” approach to treatment. Replacing the missing antibodies through immunoglobulin replacement therapy is essential for preventing infections, but it generally does not address the underlying inflammation. Therefore, patients often work with their doctors to find separate “fire-calming” medications, such as immunosuppressants or targeted biologics, to manage the overactive parts of their immune system. This ensures that while you are protected from external threats, your body is also protected from its own internal responses [4][5].

Maintaining long-term health with an IRF2BP2 diagnosis depends on a proactive partnership with a specialized care team. Because the condition can affect many different organs, you will likely work with a “team of captains”—including immunologists, pulmonologists, and gastroenterologists—who monitor your lungs, gut, and blood through regular check-ups. While the diagnosis is rare and life-long, having a clear genetic answer can help personalize monitoring, inform family genetic counseling, and provide a clearer understanding of your unique immune system [6][7].

Common questions in this guide

What is IRF2BP2-related immunodeficiency?
It is a rare genetic inborn error of immunity caused by a change in the IRF2BP2 gene. The condition can cause both CVID-like antibody deficiency, which raises infection risk, and excessive inflammation that may affect several organs.
Is IRF2BP2-related immunodeficiency the same as common variable immunodeficiency?
It can look like common variable immunodeficiency because both conditions involve antibody deficiency and recurrent infections. However, IRF2BP2-related disease has an identified genetic cause and may also include significant immune dysregulation or inflammation.
Why can this condition cause both infections and inflammation?
IRF2BP2 helps regulate the immune system’s response. When it does not work properly, the body may make too few protective antibodies while the immune system remains overly active and inflames healthy tissues.
How are infections and inflammation treated in IRF2BP2-related immunodeficiency?
Immunoglobulin replacement therapy supplies missing antibodies and helps prevent infections. Immunosuppressants or targeted biologic medicines may be used separately to calm inflammation, with choices tailored to the person’s symptoms and IRF2BP2 variant.
Which specialists should be involved in care?
An immunologist can help coordinate care, with pulmonology and gastroenterology involved when the lungs or digestive system are affected. Regular monitoring may include check-ups focused on the lungs, gut, and blood.
Should my relatives have genetic testing?
Because the condition is genetic, discuss family screening with a genetic counselor or clinician familiar with the specific IRF2BP2 variant. Testing decisions should be individualized based on the variant and the family’s circumstances.

Get notified when new evidence is published on Common variable immunodeficiency phenotype due to IRF2BP2 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation.

    Udemgba C, Pillay B, Shafer S, et al.

    The Journal of allergy and clinical immunology 2025; (155(6)):2052-2062.e5 doi:10.1016/j.jaci.2025.02.038.

    PMID: 40090425
  2. 2

    Novel frameshift variants expand the map of the genetic defects in IRF2BP2.

    García-Aznar JM, Maneiro Pampín E, García Ramos M, et al.

    Frontiers in immunology 2023; (14()):1279171 doi:10.3389/fimmu.2023.1279171.

    PMID: 37876937
  3. 3

    An IRF2BP2 Variant in a Pediatric Patient with Common Variable Immunodeficiency.

    Tekcan D, Ceylan A, Kulhas Celik I, Artac H

    Pediatric allergy, immunology, and pulmonology 2025; (38(3)):100-104 doi:10.1177/2151321X251360561.

    PMID: 40689779
  4. 4

    CVID Enteropathy Is Difficult To Treat and Shows a Heterogeneous Histopathology.

    Juliana NM, Severs M, Marsden JW, et al.

    Journal of clinical immunology 2025; (45(1)):129.

    PMID: 41026260
  5. 5

    What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review.

    Jones GL, Vogt KS, Chambers D, et al.

    Frontiers in immunology 2018; (9()):1308 doi:10.3389/fimmu.2018.01308.

    PMID: 30034388
  6. 6

    Defining Common Variable Immunodeficiency Disorders in 2020.

    Ameratunga R, Allan C, Woon ST

    Immunology and allergy clinics of North America 2020; (40(3)):403-420 doi:10.1016/j.iac.2020.03.001.

    PMID: 32654689
  7. 7

    Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review.

    Lee EY, Betschel S, Grunebaum E

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):21 doi:10.1186/s13223-022-00661-7.

    PMID: 35264237

This page provides educational information about IRF2BP2-related immunodeficiency and does not replace medical advice. An immunologist and other specialists should interpret your genetic findings and tailor infection prevention and inflammation treatment to you.